Steatosis and fibrosis in patients with chronic hepatitis C

Journal of Clinical Pathology

Volumn 57, Issue 4, 2004, Pages 402-406

  Wyatt, J ^a   Baker, H ^a   Prasad, P ^a   Gong, Y Y ^c   Millson, C ^b  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b St James's Hospital   (United States)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FATTY LIVER; HEPATITIS C; HUMAN; HUMAN TISSUE; INFLAMMATION; LIVER BIOPSY; LIVER FIBROSIS; LIVER NECROSIS; LIVER RESECTION; LIVER TRANSPLANTATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BIOPSY; CROSS-SECTIONAL STUDIES; FATTY LIVER; FEMALE; FIBROSIS; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; SEX FACTORS; TIME FACTORS;

EID: 1842507144     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2003.009357     Document Type: Article

References (27)

1. Fontaine H, Nalpas B, Poulet B, et al. Hepatic activity index is a key factor in determining the natural history of chronic hepatitis C. Hum Pathol 2001;32:904-9.
2. Koukoulis GK. Chronic hepatitic C: grading, staging and searching for reliable predictions of outcome. Hum Pathol 2001;32:899-903.
3. Yano M, Kumada H, Kage M, et al. The long term pathological evolution of chronic hepatitis C. Hepatology 1996;23:1334-40.
4. Poynard T, Bedossa P, Opalon P. Natural history of liver fibrosis prognosis in patients with chronic hepatitis C. Lancet 1997;349:825-32.
5. Kage M, Shimamatu K, Nakashima E, et al. Long-term evolution of fibrosis from chronic hepatitis to cirrhosis in patients with hepatitis C: morphometric analysis of repeated biopsies. Hepatology 1997;25;1028-31.
6. Seef LB. Natural history of hepatitis C. Hepatology 1197;26(suppl 1):215-85.
7. Hwang SJ, Luo J-C, Chu CW, et al. Hepatic steatosis in chronic hepatitis C virus infections; prevalence and clinical correlation. J Gastroenterol Hepatol 2001;16:190-5.
8. Adinolfi LE, Gambardella M, Adreana A, et al. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 2001;33:1358-64.
9. Czaja AJ, Carpenter HA. Sensitivity, specificity and predictability of biopsy interpretations in chronic hepatitis. Gastroenterology 1993;105:1824-32.
10. Rubbia-Brandt L, Leandro G, Spahr L, et al. Liver steatosis in chronic hepatitis C: a morphological sign suggesting infection with HCV genotype 3. Histopathology 2001;39:119-24.
11. Czaja AJ, Carpenter HA, Santrach P, et al. Host and disease specific factors affecting steatosis in chronic hepatitis C. J Hepatol 1998;29:198-206.
12. Quadri R, Rubbia-Brandt L, Abid K, et al. Detection of the negative-strand hepatitis C virus RNA in tissues; implications for pathogenesis. Antiviral Res 2001;52:161-71.
13. Rubbia-Brandt L, Quadri R, Abid K, et al. Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. J Hepatol 2000;33:106-15.
14. Wong VS, Wight DGD, Palmer CR, et al. Fibrosis and other histological features in chronic hepatitis C virus infections: a statistical model. J Clin Pathol 1996;49:465-9.
15. Adinoffi LE, Utili R, Adreana A, et al. Serum HCV RNA levels correlate with histological liver damage and concur with steatosis in progression of hepatitis C. Dig Dis Sci 2001;46:1677-83.
16. Hourigan LF, MacDonald GA, Purdie D, et al. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 1999;29:1215-19.
17. Petit JM, Bour JB, Galland-Jos C, et al. Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C. J Hepatol 2001;35:279-83.
18. Castera L, Hezode C, Routot-Thoraval F, et al. Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies. Gut 2003;52:288-92.
19. Powell EE, Cooksley WG, Hanson R, et al. The natural history of non-alcoholic steatohepatitis: a follow-up study of 42 patients for up to 21 years. Hepatology 1990;11:74-80.
20. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-9.
21. Bedossa P, Poynard T, Metavir co-operative study group. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996;24:289-93.
22. Knodell RG, Ishak KG, Block WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-5.
23. Desmet VJ, Gerber M, Hoofnagle JH, et al. Classification of chronic hepatitis; diagnosis, grading and staging. Hepatology 1994;19:1513-20.
24. The French Metavir Cooperative Study Group. Introobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994;20:15-20.
25. Samerasinghe D, Tasman-Jones C. The associations with hepatic steatosis: a retrospective study. N Z Med J 1992;105:57-8.
26. Hickman U, Clouston AD, Macdonald GA, et al. Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C. Gut 2002;51:89-94.
27. Negro F. Hepatitis C virus and liver steatosis: is it the virus? Yes it is, but not always. Hepatology 2002;36:1050-2.